Noerr advises banking consortium on syndicated acquisition financing for Dermapharm Holding SE

Noerr has advised a banking consortium led by Bayerische Landesbank and Landesbank Baden-Württemberg on syndicated loan financing for Dermapharm Holding SE. The other consortium banks include Commerzbank Aktiengesellschaft; Crédit Agricole Corporate and Investment Bank Deutschland; ING Bank, a branch of ING-DiBa AG; and DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main.

The lines of credit will be used to redeem an existing consortium financing agreement and to finance the acquisition of the Arkopharma Group from Montagu Private Equity.

Headquartered in Grünwald near Munich, Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Dermapharm was founded in 1991 and has more than 2,500 employees worldwide. It holds more than 1,200 marketing authorizations for more than 380 active pharmaceutical ingredients.

Advisors to the banking consortium:

Noerr Partnerschaftsgesellschaft mbB

Andreas Naujoks, Torsten Wehrhahn and Michael Schuhmacher (all Financing, Frankfurt) 

BayernLB:

Legal and Board Staff divisions: Tobias Schmidt